The beneficial effect of yoghurt consumption on health and on the improvement of the mucosal immune system is well established, as is the diet-associated risk of colon cancer. In an experimental model in BALB=c mice we demonstrated that yoghurt added to the diet for 10 consecutive days, with the procedure repeated each 10 days for 6 months, inhibited the development of a colorectal carcinoma induced by 1,2 dimethylhydrazine (DMH). The immunoregulatory mechanisms involved in the inhibition of tumour growth by yoghurt were also examined in these studies. We determined B lymphocytes IgA þ and IgG þ , as well as CD4 þ and CD8 þ T cells in the large intestine. We measured cellular apoptosis and the cytokines TNF-a, IFN-g and IL-10. An increase in the number of IgA þ (P < 0.01) was observed, but not in IgG þ (P < 0.01), or in the CD4 þ population (P < 0.01) in the mice treated with DMH and yoghurt. While in the group with the carcinogen there was an enhancement in the IgG þ B cells (P < 0.01) and CD8 þ T cells (P < 0.01). Yoghurt increased the number of apoptotic cells and induced IFN-g and TNFa cytokine release, their production being regulated by an increase in IL-10 (P < 0.001). We demonstrated that yoghurt may exert antitumour activity by a decrease in the inflammatory immune response mediated by IgA þ increase, apoptosis induction and IL-10 release.
Introduction
Colorectal cancer is a major cause of death from cancer. The colonic epithelium is a tissue with a high cell turnover rate; in this tissue the balance between cell proliferation and death is important for maintenance of the constant crypt length. It is important to maintain the balance between proliferation, differentiation and cell death to avoid the development of colorectal carcinogenesis. In this aspect diet is a predisposing factor for tumour development (Caderni et al, 1999) .
The consumption of dairy products containing viable microorganisms in the form of yoghurt and other fermented milks has increased over the last few decades due to their beneficial effect on health. They have also received special attention in the prevention of colon cancer. The live microbial feeds added to improve the intestinal microbial balance are now known as probiotics (Fuller, 1989 ) and they include not only preparations designed to act as probiotics, but also traditional yoghurt and other fermented products. The most commonly used microorganisms in probiotic preparations are the lactic acid bacteria. This approach is attractive as a means of repairing an intestinal deficiency by reconstituting the natural flora. It also avoids the intake of foreign chemicals such as antibiotics used to treat gastrointestinal infections and improve the growth of farm animals. Probiotics can also stimulate the systemic and secretory immune response (Perdigó n et al, 2001 , Vintiñi et al, 2000 .
Immunological properties of yoghurt
Traditional yoghurt contains viable cells of two species of lactic acid bacteria, Lactobacillus delbrueckii ssp. bulgaricus and Streptococcus thermophilus. In fresh yoghurt the amount of these microorganisms together are in a concentration of 10 8 cells=ml. The usual site of bacterial action in the human body is the intestine.
The beneficial effects of yoghurt have been extensively reviewed. In addition to its nutritional properties, yoghurt increases the bioavailability of many essential nutrients such as Ca, Mg and Zn ions (Dupuis et al, 1985; McDonough et al, 1985) . It allows the absorption of lactose in hydrolysed form, an important factor in the case of lactose-intolerant indivi-duals (Kolars et al, 1984) . The health benefits of yoghurt consumption have also been studied in children, young adults and in elderly persons (Lesourd et al, 1998) . Fermented milk, freeze-dried lactic acid bacteria, and extracts of fermented milk have been also reported to inhibit mutagenic compounds in various test systems (Matar et al, 1997) . The discovery of dietary compounds that can inhibit mutagenesis and potentially carcinogenesis in humans has stimulated great interest in the mechanisms by which these microorganisms or products like yoghurt can exert antitumour activity. In relation to antitumour effect of yoghurt, in both animal and in vitro studies, yoghurt has been shown to inhibit certain tumours, and may reduce the risk of colon cancer either by reduction of the carcinogen itself or by reducing the enzymes that promote the conversion of precarcinogen to carcinogen (Bodana & Rao, 1993; Goldin, 1990) .
We demonstrated the effect of giving yoghurt supplements to BALB=c mice on the various gut associated lymphoid cells. We observed an increase in the host's defence mechanisms at the intestinal mucosa; the optimal administration period being for 7 or 10 consecutive days (Perdigó n et al, 1994) . The effect of yoghurt on the activation of immune cells associated with intestinal mucosa could also be related to the effect of yoghurt or other fermented milks on the inhibition of a colon tumour (Kampman et al, 1994) .
It is known that oral antigens can induce mucosal stimulation. This stimulation can induce a clonal expansion and can activate the immune cells associated with the intestine, and stimulate the release of biologic messengers such as cytokines. The secretory immune response is mediated by IgA. This immunoglobulin forms a non-specific intestinal barrier and it is mainly involved in the protection against intestinal infections (Brandtzaeg, 1995) .
Yoghurt as immunomodulator in colon cancer prevention
In an experimental model in BALB=c mice we induced an intestinal tumour using the carcinogen 1,2 dimethylhydrazine (DMH). We observed that yoghurt supplements every 10 days for 6 months inhibited tumour development. We suggested that one of the mechanisms by which yoghurt exerts antitumour activity is through its immunomodulatory response mediated by a severe reduction (down regulation) of the inflammatory response induced by the carcinogen (Perdigó n et al, 1998; Valdez et al, 1997) . However, we cannot ignore the possibility that the intestinal inflammatory process preceding tumour development may be due to change in the epithelial cell induced by the carcinogen which enters the intestine as glucuronide, and where the normal microflora has the important role of deconjugating this compound by enzymes synthesized by gut microorganisms. Lactic acid bacteria present in yoghurt could play a role in this process.
To evaluate the hypothesis of down regulation induced by yoghurt, we explored the possible immunological mechanisms by which yoghurt can modulate the inflammatory immune response, measuring IgA
þ T cells. We also focused our study on the analysis of regulatory mechanisms of tumour growth such as apoptosis (programmed cell death), as was documented by Butler et al (1999) . In this mechanism individual cells are triggered to undergo self-destruction in a manner that will neither injure neighbouring cells nor elicit any inflammatory reaction. The role of CD4 þ T lymphocytes as producers of cytokines like IFN-g and the regulatory effect of other cytokines like TNF-a and IL10 were also analysed. Tumour necrosis factor (TNF-a) is a proinflammatory cytokine; however, high levels of TNFa can induce signals related to cell death by apoptosis (Screaton & Xu, 2000) . Lactic acid bacteria are good producers of many cytokines (Maassen et al, 2000) .
We performed experiments in different groups of mice: one group was treated only with DMH (20 mg=kg body weight once a week for 8 weeks) to induce tumour growth. Two groups were given yoghurt (simulated commercial yoghurt prepared in our laboratory) as a supplement to their diets for 10 consecutive days. One of them was injected with DMH and yoghurt feeding was repeated every 10 days for 6 months. The other group was only treated with yoghurt, every 10 days for 6 months, to determine the effect of long periods of yoghurt feeding on the parameters assayed.
The numbers of IgG þ or IgA þ , and CD4 þ or CD8 þ cells were measured after 2, 3, 4, 5 and 6 months on the histological slices from large intestine by a direct immunofluorescence assay. There was a significant increase in the number of IgA þ secreting cells (P < 0.01) in mice treated with yoghurt and injected with DMH compared with normal controls. IgG þ cells were not enhanced in this group, but they showed a marked increase in all the periods in the group with DMH and no yoghurt. The CD4 þ population was not enhanced in the group treated only with the carcinogen, but ND ¼ not determined. *P < 0.01; **P < 0.001.
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Yoghurt and cancer prevention G Perdigón et al S67 addition of yoghurt to the diet resulted in a significant increase of these cells, in all the months studied. CD8 þ cells were only increased in the group treated with DMH. Apoptosis was measured in the large intestine for the presence of DNA breaks, detected in situ by TUNEL test using fluorescein detection. In these experiments, in the group treated with DMH we saw an increase (P < 0.01) in the number of apoptotic cells for the period of the 2nd month, in relation to the unfed controls. Then these values decreased when the tumour grew. In mice treated with DMH and fed with yoghurt we observed an increase in the number of apoptotic cells in all the periods assayed. These results were similar to the group fed only with yoghurt, meaning that yoghurt favours cellular apoptosis (Table 1) .
When we analysed the cytokines TNFa, IFNg and IL-10, determined on histological slices from large intestine by immunohistochemical test, using fluorescent antibodies, we observed a marked increase (P < 0.001) of TNFa in the group injected only with the carcinogen, however in the mice treated with yoghurt the increase was also significant (P < 0.001) for the period of 5 months. In the case of INFg we observed an enhancement of this cytokine in all the periods assayed and for all the groups, with regard to the normal controls. For IL-10 we saw a significant increased (P < 0.001) for all the groups, after 6 months these values diminished, especially in the group with DMH plus yoghurt (Figure 1 ).
Conclusions
Considering the above results, in the carcinogensis induced by DMH, yoghurt increased the numbers of IgA but not IgG secreting cells. This enhancement could contribute to the limitation of the inflammatory immune response since IgA is also considered to be an immune barrier in colonic neoplasia (Isaacson, 1982) . The large number of IgG producing cells in the group injected only with DMH could justify the increase in the inflammatory response as well as the increase in the number of CD8 þ cytotoxic cells. The values obtained for CD4 þ cells may help decrease the inflammatory response due to the release of some cytokines such as INF-g which is able to kill colonic epithelial cells (Numata et al, 1991) .
We demonstrated that yoghurt feeding favoured apoptosis and this increase in the apoptotic mechanisms could be responsible for the decrease in the inflammatory response. Yoghurt also induced good levels of INF-g, TNF-a and IL-10. This last interleukin plays an important role in the downregulation of the immune response.
Throughout our studies we saw that yoghurt feeding maintains an adequate intestinal immune response with an enhancement in the regulatory immune mechanisms mediated by a larger number of IgA þ cells, production of TNF-a and IL-10 cytokines that favour the apoptosis mechanisms or immune down-regulation, respectively. We demonstrated that at least one of the mechanisms by which yoghurt inhibits the establishment and growth of an experimental intestinal carcinoma is through its capacity to modulate the mucosal gut immune response.
